Occupation as a risk factor of small cell lung cancer.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
23 03 2023
23 03 2023
Historique:
received:
14
12
2022
accepted:
21
03
2023
entrez:
24
3
2023
pubmed:
25
3
2023
medline:
28
3
2023
Statut:
epublish
Résumé
Small cell lung cancer (SCLC) comprises approximately 10% of all lung cancer cases. Tobacco is its main risk factor; however, occupation might play a role in this specific lung cancer subtype. The effect of occupation on SCLC risk has been hardly studied and therefore we aim to assess the role of occupation on the risk of SCLC. To do this, we designed a multicentric, hospital-based, case-control study. Cases consisted exclusively in SCLC patients and controls were recruited from patients having minor surgery at the participating hospitals. Face to face interviews emphasizing occupation and tobacco consumption were held and residential radon was also measured. Logistic regression models were adjusted with odds ratios with 95%CI as estimations of the effect. 423 cases and 905 controls were included. Smoking prevalence was higher in cases compared to controls. Those who worked in known-risk occupations for lung cancer showed an OR of 2.17 (95%CI 1.33; 3.52), with a similar risk when men were analysed separately. The results were adjusted by age, sex, smoking and indoor radon exposure. Those who worked in known-risk occupations and were moderate or heavy smokers had a SCLC risk of 12.19 (95%CI 5.68-26.38) compared with never or moderate smokers who had not worked in such occupations. Occupation is a relevant risk factor of SCLC, and it seems that its effect is boosted when tobacco smoking is present.
Identifiants
pubmed: 36959236
doi: 10.1038/s41598-023-31991-0
pii: 10.1038/s41598-023-31991-0
pmc: PMC10036470
doi:
Substances chimiques
Radon
Q74S4N8N1G
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4727Informations de copyright
© 2023. The Author(s).
Références
Int J Occup Environ Health. 1998 Oct-Dec;4(4):236-40
pubmed: 9876632
Occup Environ Med. 2022 Mar;79(3):207-214
pubmed: 33972375
Cancer Epidemiol. 2015 Dec;39 Suppl 1:S1-10
pubmed: 26164654
Epidemiology. 2017 Mar;28(2):288-299
pubmed: 28141674
Am J Ind Med. 2003 Feb;43(2):149-55
pubmed: 12541269
Cancer Lett. 2018 Jul 10;426:57-62
pubmed: 29654890
Rev Port Cardiol (Engl Ed). 2019 Aug;38(8):583-593
pubmed: 31679648
Ann Oncol. 2013 Oct;24 Suppl 6:vi99-105
pubmed: 23813929
Carcinogenesis. 2019 Jul 6;40(6):724-734
pubmed: 31038674
PLoS One. 2015 Aug 14;10(8):e0135798
pubmed: 26274395
Am J Respir Crit Care Med. 2020 Aug 1;202(3):402-411
pubmed: 32330395
Am J Ind Med. 2009 Mar;52(3):221-32
pubmed: 19058264
J Toxicol Environ Health A. 2009;72(10):658-75
pubmed: 19308851
Occup Environ Med. 2010 Aug;67(8):519-25
pubmed: 20647379
ESMO Open. 2021 Apr;6(2):100059
pubmed: 33640828
Arch Bronconeumol. 2022 Jul;58(7):542-546
pubmed: 35312555
Am J Ind Med. 2012 May;55(5):412-22
pubmed: 22237930
CA Cancer J Clin. 2021 Jan;71(1):7-33
pubmed: 33433946
J Occup Environ Med. 2011 Sep;53(9):1068-77
pubmed: 21866050
Arch Toxicol. 2018 May;92(5):1785-1795
pubmed: 29523930
Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1433-1441
pubmed: 35437574
Am J Respir Crit Care Med. 2020 Aug 1;202(3):412-421
pubmed: 32330394
J Radiol Prot. 2017 Sep;37(3):728-741
pubmed: 28608782
Am J Epidemiol. 2010 Feb 1;171(3):323-33
pubmed: 20047975